Article info

In vitro efficacy of topical ophthalmic antiseptics against SARS-CoV-2

Authors

  • Tina Felfeli Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Ontario, CanadaDalla Lana School of Public Health, University of Toronto, Toronto, Ontario, CanadaKensington Vision and Research Centre, Kensington Eye Institute, University of Toronto, Toronto, Ontario, Canada PubMed articlesGoogle scholar articles
  • Samantha B Kasloff J.C. Wilt Infectious Diseases Research Centre, Public Health Agency of Canada Ontario Manitoba Saskatchewan Regional Office, Winnipeg, Manitoba, CanadaCanadian Science Centre for Human and Animal Health, Winnipeg, Manitoba, Canada PubMed articlesGoogle scholar articles
  • Jay Krishnan J.C. Wilt Infectious Diseases Research Centre, Public Health Agency of Canada Ontario Manitoba Saskatchewan Regional Office, Winnipeg, Manitoba, CanadaCanadian Science Centre for Human and Animal Health, Winnipeg, Manitoba, Canada PubMed articlesGoogle scholar articles
  • Sherif R El-Defrawy Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Ontario, CanadaKensington Vision and Research Centre, Kensington Eye Institute, University of Toronto, Toronto, Ontario, Canada PubMed articlesGoogle scholar articles
  • Tony Mazzulli Department of Microbiology, Mount Sinai Hospital, University Health Network, Toronto, Ontario, CanadaDepartment of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, CanadaPublic Health Ontario Laboratory, Toronto, Ontario, Canada PubMed articlesGoogle scholar articles
  • Todd A Cutts J.C. Wilt Infectious Diseases Research Centre, Public Health Agency of Canada Ontario Manitoba Saskatchewan Regional Office, Winnipeg, Manitoba, CanadaCanadian Science Centre for Human and Animal Health, Winnipeg, Manitoba, Canada PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Tina Felfeli; tina.felfeli{at}mail.utoronto.ca
View Full Text

Citation

Felfeli T, Kasloff SB, Krishnan J, et al
In vitro efficacy of topical ophthalmic antiseptics against SARS-CoV-2

Publication history

  • First published June 9, 2021.
Online issue publication 
June 09, 2021
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.